Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered adsorption filters
- 12 February 2025
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 614, 217546
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Large‐scale heparin‐based bind‐and‐elute chromatography identifies two biologically distinct populations of extracellular vesiclesJournal of Extracellular Vesicles, 2023
- Circulating extracellular vesicles and tumor cells: sticky partners in metastasisTrends in Cancer, 2022
- Preanalytical Variables for the Genomic Assessment of the Cellular and Acellular Fractions of the Liquid Biopsy in a Cohort of Breast Cancer PatientsThe Journal of Molecular Diagnostics, 2020
- Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancerCancer Letters, 2019
- Exosomes and Ectosomes in Intercellular CommunicationCurrent Biology, 2018
- Plasma Proteome Profiling to Assess Human Health and DiseaseCell Systems, 2016
- Extracellular Vesicles in Cancer: Exosomes, Microvesicles and the Emerging Role of Large OncosomesSeminars in Cell & Developmental Biology, 2015
- Circulating tumor cells: a window into cancer biology and metastasisCurrent Opinion in Genetics & Development, 2010
- Heparin-mediated extracorporeal low density lipoprotein precipitation as a possible therapeutic approach in preeclampsiaTransfusion and Apheresis Science, 2006
- Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins—reduction of circulating proinflammatory and procoagulatory markersAtherosclerosis, 2004